Skip to main content

Infectious Esophagitis

  • Chapter
  • First Online:
Principles of Deglutition

Abstract

Infectious esophagitis is relatively rare in an immunocompetent host. The presence of an esophageal infection is usually indicative of an impairment of either local or systemic defense mechanisms that normally act to prevent the colonization of a digestive organ that has a relatively transient contact with swallowed microbes. The spectrum of esophageal infections has changed over the past few decades. Esophageal infections were rare before the advent of acquired immune deficiency syndrome (AIDS) and posttransplant immunosuppressive treatment regimens with case reports largely confined to autopsy series. The explosion in opportunistic esophageal infections heralded by human immunodeficiency virus (HIV) and medication treatment-induced immunosuppression has been largely reversed by the efficacy of highly active retroviral therapy (HAART) in treating HIV and refinements in immunosuppressive therapy and transplant management in general [ 1– 3 ]. Nevertheless, socioeconomic barriers to widespread availability of HAART, a lack of compliance, and continued use of immunosuppressive therapy in a variety of diseases will likely perpetuate the morbidity from esophageal infections.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AIDS:

Acquired immune deficiency syndrome

CMV:

Cytomegalovirus

HAART:

Highly active retroviral therapy

HIV:

Human immunodeficiency virus

HSV:

Herpes simplex virus

PCR:

Polymerase chain reaction

TB:

Tuberculosis

VZV:

Varicella-zoster virus

References

  1. Raufman JP. Declining gastrointestinal opportunistic infections in HIV-infected persons: a triumph of science and a challenge for our HAARTs and minds. Am J Gastroenterol. 2005;100(7):1455–8.

    Article  PubMed  Google Scholar 

  2. Mocroft A, Oancea C, van Lunzen J, Vanhems P, Banhegyi D, Chiesi A, et al. Decline in esophageal candidiasis and use of antimycotics in European patients with HIV. Am J Gastroenterol. 2005;100(7):1446–54.

    Article  PubMed  Google Scholar 

  3. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091–101.

    Article  PubMed  CAS  Google Scholar 

  4. McDonald GB, Sharma P, Hackman RC, Meyers JD, Thomas ED. Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology. 1985;88(5 Pt 1):1111–7.

    PubMed  CAS  Google Scholar 

  5. Monkemuller KE, Lazenby AJ, Lee DH, Loudon R, Wilcox CM. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci. 2005;50(2):230–4.

    Article  PubMed  Google Scholar 

  6. Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs. 2010;70(8):965–81.

    Article  PubMed  CAS  Google Scholar 

  7. Ramanathan J, Rammouni M, Baran Jr J, Khatib R. Herpes simplex virus esophagitis in the immunocompetent host: an overview. Am J Gastroenterol. 2000;95(9):2171–6.

    Article  PubMed  CAS  Google Scholar 

  8. Scott BB, Jenkins D. Gastro-oesophageal candidiasis. Gut. 1982;23(2):137–9.

    Article  PubMed  CAS  Google Scholar 

  9. Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology. 1994;106(2):509–32.

    PubMed  CAS  Google Scholar 

  10. Badarinarayanan G, Gowrisankar R, Muthulakshmi K. Esophageal candidiasis in non-immune suppressed patients in a semi-urban town, southern India. Mycopathologia. 2000;149(1):1–4.

    Article  PubMed  CAS  Google Scholar 

  11. Kjellin AP, Ost AE, Pope 2nd CE. Histology of esophageal mucosa from patients with achalasia. Dis Esophagus. 2005;18(4):257–61.

    Article  PubMed  CAS  Google Scholar 

  12. Hendel L, Svejgaard E, Walsoe I, Kieffer M, Stenderup A. Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole. Scand J Gastroenterol. 1988;23(10):1182–6.

    Article  PubMed  CAS  Google Scholar 

  13. Aun MV, Ribeiro MR, Costa Garcia CL, Agondi RC, Kalil J, Giavina-Bianchi P. Esophageal candidiasis–an adverse effect of inhaled corticosteroids therapy. J Asthma. 2009;46(4):399–401.

    Article  PubMed  CAS  Google Scholar 

  14. Kanda N, Yasuba H, Takahashi T, Mizuhara Y, Yamazaki S, Imada Y, et al. Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate. Am J Gastroenterol. 2003;98(10):2146–8.

    Article  PubMed  CAS  Google Scholar 

  15. Koyama S, Watanabe M, Iijima T. Esophageal intramural pseudodiverticulosis (diffuse type). J Gastroenterol. 2002;37(8):644–8.

    Article  PubMed  Google Scholar 

  16. Kirkpatrick CH. Chronic mucocutaneous candidiasis. J Am Acad Dermatol. 1994;31(3 Pt 2):S14–7.

    Article  PubMed  CAS  Google Scholar 

  17. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322(26):1829–36.

    Article  PubMed  CAS  Google Scholar 

  18. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601–14.

    Article  PubMed  CAS  Google Scholar 

  19. Veroux M, Macarone M, Fiamingo P, Cappello D, Gagliano M, Di Mare M, et al. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. Transplant Proc. 2006;38(4):1037–9.

    Article  PubMed  CAS  Google Scholar 

  20. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med. 2002;112(5):380–5.

    Article  PubMed  Google Scholar 

  21. Peleg AY, Husain S, Kwak EJ, Silveira FP, Ndirangu M, Tran J, et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis. 2007;44(2):204–12.

    Article  PubMed  CAS  Google Scholar 

  22. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133–63.

    Article  PubMed  CAS  Google Scholar 

  23. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;326(13):845–51.

    Article  PubMed  CAS  Google Scholar 

  24. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation–a prospective, randomized, double-blind study. J Infect Dis. 1995;171(6):1545–52.

    Article  PubMed  CAS  Google Scholar 

  25. Monkemuller KE, Call SA, Lazenby AJ, Wilcox CM. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol. 2000;95(2):457–62.

    PubMed  CAS  Google Scholar 

  26. Chong VH, Lim CC. Human immunodeficiency virus and endoscopy: Experience of a general hospital in Singapore. J Gastroenterol Hepatol. 2005;20(5):722–6.

    Article  PubMed  Google Scholar 

  27. Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin Infect Dis. 2004;38(10):1447–53.

    Article  PubMed  Google Scholar 

  28. Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluco­nazole resistance. Am J Med. 1994;97(4):339–46.

    Article  PubMed  CAS  Google Scholar 

  29. Phillips P, Zemcov J, Mahmood W, Montaner JS, Craib K, Clarke AM. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility. AIDS. 1996;10(12):1369–76.

    Article  PubMed  CAS  Google Scholar 

  30. Wilcox CM, Straub RF, Clark WS. Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulceration. Am J Gastroenterol. 1995;90(11):1938–41.

    PubMed  CAS  Google Scholar 

  31. Tavitian A, Raufman JP, Rosenthal LE. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. Ann Intern Med. 1986;104(1):54–5.

    PubMed  CAS  Google Scholar 

  32. Tran HA, Vincent JM, Slavin MA, Grigg A. Esophageal perforation secondary to angio-invasive Candida glabrata following hemopoietic stem cell transplantation. Clin Microbiol Infect. 2003;9(12):1215–8.

    Article  PubMed  CAS  Google Scholar 

  33. Hyun JJ, Chun HJ, Keum B, Seo YS, Kim YS, Jeen YT, et al. Candida esophagitis complicated by esophageal stricture. Endoscopy. 2010;42 Suppl 2:E180–1.

    Article  PubMed  Google Scholar 

  34. Kim BW, Cho SH, Rha SE, Choi H, Choi KY, Cha SB, et al. Esophagomediastinal fistula and esophageal stricture as a complication of esophageal candidiasis: a case report. Gastrointest Endosc. 2000;52(6):772–5.

    Article  PubMed  CAS  Google Scholar 

  35. Kanzaki R, Yano M, Takachi K, Ishiguro S, Motoori M, Kishi K, et al. Candida esophagitis complicated by an esophago-airway fistula: report of a case. Surg Today. 2009;39(11):972–8.

    Article  PubMed  Google Scholar 

  36. Kodsi BE, Wickremesinghe C, Kozinn PJ, Iswara K, Goldberg PK. Candida esophagitis: a prospective study of 27 cases. Gastroenterology. 1976;71(5):715–9.

    PubMed  CAS  Google Scholar 

  37. Werneck-Silva A, Prado I. The relationship between immunological status and severity of endoscopic lesions in candida esophagitis is not perfect in HIV-infected patients. Gastrointest Endosc. 2007;65(5):AB148.

    Article  Google Scholar 

  38. Andersen LI, Frederiksen HJ, Appleyard M. Prevalence of esophageal Candida colonization in a Danish population: special reference to esophageal symptoms, benign esophageal disorders, and pulmonary disease. J Infect Dis. 1992;165(2):389–92.

    Article  PubMed  CAS  Google Scholar 

  39. Pappas PG, Kauffman CA, Andes D, Benjamin Jr DK, Calandra TF, Edwards Jr JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35.

    Article  PubMed  CAS  Google Scholar 

  40. Wilcox CM, Alexander LN, Clark WS, Thompson 3rd SE. Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms. Gastroenterology. 1996;110(6):1803–9.

    Article  PubMed  CAS  Google Scholar 

  41. Ally R, Schurmann D, Kreisel W, Carosi G, Aguirrebengoa K, Dupont B, et al. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis. 2001;33(9):1447–54.

    Article  PubMed  CAS  Google Scholar 

  42. Villanueva A, Gotuzzo E, Arathoon EG, Noriega LM, Kartsonis NA, Lupinacci RJ, et al. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med. 2002;113(4):294–9.

    Article  PubMed  CAS  Google Scholar 

  43. Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, et al. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. Clin Infect Dis. 2005;41(10):1473–80.

    Article  PubMed  CAS  Google Scholar 

  44. Jacobs DH, Macher AM, Handler R, Bennett JE, Collen MJ, Gallin JI. Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job’s) syndrome. Gastroenterology. 1984;87(1):201–3.

    PubMed  CAS  Google Scholar 

  45. McKenzie R, Khakoo R. Blastomycosis of the esophagus presenting with gastrointestinal bleeding. Gastroenterology. 1985;88(5 Pt 1):1271–3.

    PubMed  CAS  Google Scholar 

  46. Alioglu B, Avci Z, Canan O, Ozcay F, Demirhan B, Ozbek N. Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B. Pediatr Hematol Oncol. 2007;24(1):63–8.

    Article  PubMed  CAS  Google Scholar 

  47. Akyol Erikci A, Ozyurt M, Terekeci H, Ozturk A, Karabudak O, Oncu K. Oesophageal aspergillosis in a case of acute lymphoblastic leukaemia successfully treated with caspofungin alone due to liposomal amphotericin B induced severe hepatotoxicity. Mycoses. 2009;52(1):84–6.

    Article  PubMed  CAS  Google Scholar 

  48. Choi JH, Yoo JH, Chung IJ, Kim DW, Han CW, Shin WS, et al. Esophageal aspergillosis after bone marrow transplant. Bone Marrow Transplant. 1997;19(3):293–4.

    Article  PubMed  CAS  Google Scholar 

  49. Chionh F, Herbert KE, Seymour JF, Prince HM, Wolf M, Zimet A, et al. Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia. Leuk Lymphoma. 2005;46(4):603–5.

    Article  PubMed  Google Scholar 

  50. Marshall JB, Singh R, Demmy TL, Bickel JT, Everett ED. Mediastinal histoplasmosis presenting with esophageal involvement and dysphagia: case study. Dysphagia. 1995;10(1):53–8.

    Article  PubMed  CAS  Google Scholar 

  51. Coss KC, Wheat LJ, Conces Jr DJ, Brashear RE, Hull MT. Esophageal fistula complicating mediastinal histoplasmosis. Response to amphotericin. Br Am J Med. 1987;83(2):343–6.

    Article  CAS  Google Scholar 

  52. Gilliland MD, Scott LD, Walker WE. Esophageal obstruction caused by mediastinal histoplasmosis: beneficial results of operation. Surgery. 1984;95(1):59–62.

    PubMed  CAS  Google Scholar 

  53. Fucci JC, Nightengale ML. Primary esophageal ­histoplasmosis. Am J Gastroenterol. 1997;92(3):530–1.

    PubMed  CAS  Google Scholar 

  54. Huppmann AR, Orenstein JM. Opportunistic disorders of the gastrointestinal tract in the age of highly active antiretroviral therapy. Hum Pathol. 2010;41(12):1777–87.

    Article  PubMed  Google Scholar 

  55. Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep. 2008;10(4):409–16.

    Article  PubMed  Google Scholar 

  56. Arthurs SK, Eid AJ, Pedersen RA, Kremers WK, Cosio FG, Patel R, et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis. 2008;46(6):840–6.

    Article  PubMed  Google Scholar 

  57. Fica A, Cervera C, Perez N, Marcos MA, Ramirez J, Linares L, et al. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests. Transplant Infect Dis. 2007;9(3):203–10.

    Article  CAS  Google Scholar 

  58. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, et al. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005;41(15):2268–79.

    Article  PubMed  Google Scholar 

  59. Wilcox CM. Esophageal strictures complicating ulcerative esophagitis in patients with AIDS. Am J Gastroenterol. 1999;94(2):339–43.

    Article  PubMed  CAS  Google Scholar 

  60. Goodgame RW, Ross PG, Kim HS, Hook AG, Sutton FM. Esophageal stricture after cytomegalovirus ulcer treated with ganciclovir. J Clin Gastroenterol. 1991;13(6):678–81.

    Article  PubMed  CAS  Google Scholar 

  61. Sheth A, Boktor M, Diamond K, Lavu K, Sangster G. Complete esophageal obliteration secondary to cytomegalovirus in AIDS patient. Dis Esophagus. 2010;23(6):E32–4.

    Article  PubMed  CAS  Google Scholar 

  62. Trappe R, Pohl H, Forberger A, Schindler R, Reinke P. Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection. Transplant Infect Dis. 2007;9(1):42–5.

    Article  CAS  Google Scholar 

  63. Monkemuller KE, Bussian AH, Lazenby AJ, Wilcox CM. Special histologic stains are rarely beneficial for the evaluation of HIV-related gastrointestinal infections. Am J Clin Pathol. 2000;114(3):387–94.

    PubMed  CAS  Google Scholar 

  64. Peter A, Telkes G, Varga M, Sarvary E, Kovalszky I. Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: Hungarian single-center experience. Clin Transplant. 2004;18(5):580–4.

    Article  PubMed  Google Scholar 

  65. Rowshani AT, Bemelman FJ, van Leeuwen EM, van Lier RA, ten Berge IJ. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation. 2005;79(4):381–6.

    Article  PubMed  Google Scholar 

  66. Koskinen PK, Nieminen MS, Mattila SP, Hayry PJ, Lautenschlager IT. The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients. Transplantation. 1993;55(3):547–51.

    Article  PubMed  CAS  Google Scholar 

  67. Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2007;7(9):2106–13.

    Article  PubMed  CAS  Google Scholar 

  68. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010;89(7):779–95.

    Article  PubMed  Google Scholar 

  69. Itoh T, Takahashi T, Kusaka K, Kawaura K, Nakagawa Y, Yamakawa J, et al. Herpes simplex esophagitis from 1307 autopsy cases. J Gastroenterol Hepatol. 2003;18(12):1407–11.

    Article  PubMed  Google Scholar 

  70. Nash G, Ross JS. Herpetic esophagitis. A common cause of esophageal ulceration. Hum Pathol. 1974;5(3):339–45.

    Article  PubMed  CAS  Google Scholar 

  71. Wishingrad M. Sexually transmitted esophagitis: primary herpes simplex virus type 2 infection in a healthy man. Gastrointest Endosc. 1999;50(6):845–6.

    Article  PubMed  CAS  Google Scholar 

  72. McBane RD, Gross Jr JB. Herpes esophagitis: clinical syndrome, endoscopic appearance, and diagnosis in 23 patients. Gastrointest Endosc. 1991;37(6):600–3.

    Article  PubMed  CAS  Google Scholar 

  73. Eisen HJ, Kobashigawa J, Keogh A, Bourge R, Renlund D, Mentzer R, et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant. 2005;24(5):517–25.

    Article  PubMed  Google Scholar 

  74. Mosimann F, Cuenoud PF, Steinhauslin F, Wauters JP. Herpes simplex esophagitis after renal transplantation. Transplant Int. 1994;7(2):79–82.

    Article  CAS  Google Scholar 

  75. Wilcox CM, Schwartz DA, Clark WS. Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy, and long-term outcome. Ann Intern Med. 1995;123(2):143–9.

    PubMed  CAS  Google Scholar 

  76. Bini EJ, Micale PL, Weinshel EH. Natural history of HIV-associated esophageal disease in the era of protease inhibitor therapy. Dig Dis Sci. 2000;45(7):1301–7.

    Article  PubMed  CAS  Google Scholar 

  77. Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med. 1991;151(8):1567–72.

    Article  PubMed  CAS  Google Scholar 

  78. Canalejo Castrillero E, Garcia Duran F, Cabello N, Garcia Martinez J. Herpes esophagitis in healthy adults and adolescents: report of 3 cases and review of the literature. Medicine (Baltimore). 2010;89(4):204–10.

    Article  Google Scholar 

  79. Dieckhaus KD, Hill DR. Boerhaave’s syndrome due to herpes simplex virus type 1 esophagitis in a patient with AIDS. Clin Infect Dis. 1998;26(5):1244–5.

    Article  PubMed  CAS  Google Scholar 

  80. Cirillo NW, Lyon DT, Schuller AM. Tracheoe­sophageal fistula complicating herpes esophagitis in AIDS. Am J Gastroenterol. 1993;88(4):587–9.

    PubMed  CAS  Google Scholar 

  81. Nagri S, Hwang R, Anand S, Kurz J. Herpes simplex esophagitis presenting as acute necrotizing esophagitis (“black esophagus”) in an immunocompetent patient. Endoscopy. 2007;39 Suppl 1:E169.

    Article  PubMed  Google Scholar 

  82. Cattan P, Cuillerier E, Cellier C, Carnot F, Landi B, Dusoleil A, et al. Black esophagus associated with herpes esophagitis. Gastrointest Endosc. 1999;49(1):105–7.

    Article  PubMed  CAS  Google Scholar 

  83. Gurvits GE, Robilotti JG. Isolated proximal black esophagus: etiology and the role of tissue biopsy. Gastrointest Endosc. 2010;71(3):658.

    Article  PubMed  Google Scholar 

  84. Higuchi D, Sugawa C, Shah SH, Tokioka S, Lucas CE. Etiology, treatment, and outcome of esophageal ulcers: a 10-year experience in an urban emergency hospital. J Gastrointest Surg. 2003;7(7):836–42.

    Article  PubMed  Google Scholar 

  85. Lavery EA, Coyle WJ. Herpes simplex virus and the alimentary tract. Curr Gastroenterol Rep. 2008;10(4):417–23.

    Article  PubMed  Google Scholar 

  86. Frobert E, Ooka T, Cortay JC, Lina B, Thouvenot D, Morfin F. Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study. Antimicrob Agents Chemother. 2005;49(3):1055–9.

    Article  PubMed  CAS  Google Scholar 

  87. Gill RA, Gebhard RL, Dozeman RL, Sumner HW. Shingles esophagitis: endoscopic diagnosis in two patients. Gastrointest Endosc. 1984;30(1):26–7.

    Article  PubMed  CAS  Google Scholar 

  88. Moretti F, Uberti-Foppa C, Quiros-Roldan E, Fanti L, Lillo F, Lazzarin A. Oesophagobronchial fistula caused by varicella zoster virus in a patient with AIDS: a unique case. J Clin Pathol. 2002;55(5):397–8.

    Article  PubMed  CAS  Google Scholar 

  89. Kitchen VS, Helbert M, Francis ND, Logan RP, Lewis FA, Boylston AW, et al. Epstein-Barr virus associated oesophageal ulcers in AIDS. Gut. 1990;31(11):1223–5.

    Article  PubMed  CAS  Google Scholar 

  90. Kranz B, Vester U, Becker J, Woltering T, Wingen AM, Paul A, et al. Unusual manifestation of posttransplant lymphoproliferative disorder in the esophagus. Transplant Proc. 2006;38(3):693–6.

    Article  PubMed  CAS  Google Scholar 

  91. Neumann H, Kuester D, Monkemuller K. Atypical esophagitis. Gastroenterology. 2009;137(3):790. 1188.

    Article  PubMed  Google Scholar 

  92. Mosca S, Manes G, Monaco R, Bellomo PF, Bottino V, Balzano A. Squamous papilloma of the esophagus: long-term follow up. J Gastroenterol Hepatol. 2001;16(8):857–61.

    Article  PubMed  CAS  Google Scholar 

  93. Smith PD, Eisner MS, Manischewitz JF, Gill VJ, Masur H, Fox CF. Esophageal disease in AIDS is associated with pathologic processes rather than mucosal human immunodeficiency virus type 1. J Infect Dis. 1993;167(3):547–52.

    Article  PubMed  CAS  Google Scholar 

  94. Wilcox CM, Zaki SR, Coffield LM, Greer PW, Schwartz DA. Evaluation of idiopathic esophageal ulceration for human immunodeficiency virus. Mod Pathol. 1995;8(5):568–72.

    PubMed  CAS  Google Scholar 

  95. Kotler DP, Reka S, Orenstein JM, Fox CH. Chronic idiopathic esophageal ulceration in the acquired immunodeficiency syndrome. Characterization and treatment with corticosteroids. J Clin Gastroenterol. 1992;15(4):284–90.

    Article  PubMed  CAS  Google Scholar 

  96. Alexander LN, Wilcox CM. A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers. AIDS Res Hum Retroviruses. 1997;13(4):301–4.

    Article  PubMed  CAS  Google Scholar 

  97. Adeoti AG, Vega KJ, Dajani EZ, Trotman BW, Kloser PC. Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: successful treatment with misoprostol and viscous lidocaine. Am J Gastroenterol. 1998;93(11):2069–74.

    Article  PubMed  CAS  Google Scholar 

  98. Richert SM, Orchard JL. Bacterial esophagitis ­associated with CD4+ T-lymphocytopenia without HIV infection. Possible role of corticosteroid treatment. Dig Dis Sci. 1995;40(1):183–5.

    Article  PubMed  CAS  Google Scholar 

  99. Ezzell Jr JH, Bremer J, Adamec TA. Bacterial esophagitis: an often forgotten cause of odynophagia. Am J Gastroenterol. 1990;85(3):296–8.

    PubMed  Google Scholar 

  100. Walsh TJ, Belitsos NJ, Hamilton SR. Bacterial esophagitis in immunocompromised patients. Arch Intern Med. 1986;146(7):1345–8.

    Article  PubMed  CAS  Google Scholar 

  101. Jain SK, Jain S, Jain M, Yaduvanshi A. Esophageal tuberculosis: is it so rare? Report of 12 cases and review of the literature. Am J Gastroenterol. 2002;97(2):287–91.

    Article  PubMed  CAS  Google Scholar 

  102. Carr D, Spain D. Tuberculosis in a carcinoma of the esophagus. Annu Rev Tubercul. 1942;46:346–9.

    Google Scholar 

  103. Park JH, Kim SU, Sohn JW, Chung IK, Jung MK, Jeon SW, et al. Endoscopic findings and clinical features of esophageal tuberculosis. Scand J Gastroenterol. 2010;45(11):1269–72.

    Article  PubMed  Google Scholar 

  104. Devarbhavi HC, Alvares JF, Radhikadevi M. Esophageal tuberculosis associated with esophagotracheal or esophagomediastinal fistula: report of 10 cases. Gastrointest Endosc. 2003;57(4):588–92.

    Article  PubMed  Google Scholar 

  105. O’Leary M, Nollet DJ, Blomberg DJ. Rupture of a tuberculous pseudoaneurysm of the innominate artery into the trachea and esophagus: report of a case and review of the literature. Hum Pathol. 1977;8(4):458–67.

    Article  PubMed  Google Scholar 

  106. Welzel TM, Kawan T, Bohle W, Richter GM, Bosse A, Zoller WG. An unusual cause of dysphagia: esophageal tuberculosis. J Gastrointestin Liver Dis. 2010;19(3):321–4.

    PubMed  Google Scholar 

  107. Yagi T, Fujino H, Hirai M, Inoue T, Sako M, Teshima H, et al. Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer/T cell lymphoma, nasal type. Bone Marrow Transplant. 2003;32(4):451–3.

    Article  PubMed  CAS  Google Scholar 

  108. Chou FT, Cheng KS, Chiang IP. Esophageal actinomycosis. Adv Ther. 2006;23(4):623–6.

    Article  PubMed  Google Scholar 

  109. Murchan EM, Redelman-Sidi G, Patel M, Dimaio C, Seo SK. Esophageal actinomycosis in a fifty-three-year-old man with HIV: case report and review of the literature. AIDS Patient Care STDS. 2010;24(2):73–8.

    Article  PubMed  Google Scholar 

  110. Arora AK, Nord J, Olofinlade O, Javors B. Esophageal actinomycosis: a case report and review of the literature. Dysphagia. 2003;18(1):27–31.

    Article  PubMed  Google Scholar 

  111. Lee SA, Palmer GW, Cooney EL. Esophageal actinomycosis in a patient with AIDS. Yale J Biol Med. 2001;74(6):383–9.

    PubMed  CAS  Google Scholar 

  112. Sudhakar SS, Ross JJ. Short-term treatment of actinomycosis: two cases and a review. Clin Infect Dis. 2004;38(3):444–7.

    Article  PubMed  Google Scholar 

  113. Hudson TR, Head JR. Syphilis of the esophagus. J Thorac Surg. 1950;20(2):216–21.

    PubMed  CAS  Google Scholar 

  114. Stone J, Friedberg SA. Obstructive syphilitic esophagitis. J Am Med Assoc. 1961;177(10):711.

    Article  Google Scholar 

  115. Padovan W, Godoy RA, Dantas RO, Meneghelli UG, Oliveira RB, Troncon LE. Lower oesophageal sphincter response to pentagastrin in chagasic patients with megaoesophagus and megacolon. Gut. 1980;21(2):85–90.

    Article  PubMed  CAS  Google Scholar 

  116. Matsuda NM, Miller SM, Evora PR. The chronic gastrointestinal manifestations of Chagas disease. Clinics (Sao Paulo). 2009;64(12):1219–24.

    Article  Google Scholar 

  117. Gutierrez-Macias A, Alonso-Alonso JJ, Aguirre-Errasti C. Esophageal leishmaniasis in a patient infected with the human immunodeficiency virus. Clin Infect Dis. 1995;21(1):229–30.

    Article  PubMed  CAS  Google Scholar 

  118. Laguna F, Garcia-Samaniego J, Soriano V, Valencia E, Redondo C, Alonso MJ, et al. Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis. 1994;19(1):48–53.

    Article  PubMed  CAS  Google Scholar 

  119. Villanueva JL, Torre-Cisneros J, Jurado R, Villar A, Montero M, Lopez F, et al. Leishmania esophagitis in an AIDS patient: an unusual form of visceral leishmaniasis. Am J Gastroenterol. 1994;89(2):273–5.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph A. Murray MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Namasivayam, V., Murray, J.A. (2013). Infectious Esophagitis. In: Shaker, R., Belafsky, P., Postma, G., Easterling, C. (eds) Principles of Deglutition. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3794-9_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3794-9_46

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3793-2

  • Online ISBN: 978-1-4614-3794-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics